Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome

被引：0
|
作者：
Borthakur, Gautam [1 ]
Estrov, Zeev [1 ]
Garcia-Manero, Guillermo [1 ]
Williams, Betsy [1 ]
Wathen, Jay K. [1 ]
Konopleva, Marina [1 ]
Burger, Jan [1 ]
Ferrajoli, Alessandra [1 ]
George, Solly [1 ]
Kantarjian, Hagop [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Quantitat Sci Div, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1026 / 1026
页数：1
相关论文
共 50 条
  • [1] Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
    Daver, Naval
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Konopleva, Marina
    Burger, Jan A.
    O'Brien, Susan
    Ferrajoli, Alessandra
    Verstovsek, Srdan
    Kadia, Tapan M.
    Jabbour, Elias J.
    Faderl, Stefan
    Diaz-Pines-Mateo, Maria
    Pemmaraju, Naveen
    Pierce, Sherry A.
    Cortes, Jorge E.
    Borthakur, Gautam
    [J]. BLOOD, 2012, 120 (21)
  • [2] Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
    Chen, Y.
    Kantarjian, H.
    Garcia-Manero, G.
    Estrov, Z.
    Konopleva, M.
    Jabbour, E.
    Kadia, T. M.
    Williams, E.
    George, S.
    Borthakur, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase 2 Study of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome- Outcome in Previously Untreated Patients.
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Konopleva, Marina
    Burger, Jan A.
    Thomas, Deborah A.
    Kadia, Tapan
    Williams, Betsy
    George, Sully
    Kantarjian, Hagop
    [J]. BLOOD, 2009, 114 (22) : 435 - 436
  • [4] A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
    Daver, N.
    Kantarjian, H.
    Ravandi, F.
    Estey, E.
    Wang, X.
    Garcia-Manero, G.
    Jabbour, E.
    Konopleva, M.
    O'Brien, S.
    Verstovsek, S.
    Kadia, T.
    Dinardo, C.
    Pierce, S.
    Huang, X.
    Pemmaraju, N.
    Diaz-Pines-Mateo, M.
    Cortes, J.
    Borthakur, G.
    [J]. LEUKEMIA, 2016, 30 (02) : 268 - 273
  • [5] A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
    N Daver
    H Kantarjian
    F Ravandi
    E Estey
    X Wang
    G Garcia-Manero
    E Jabbour
    M Konopleva
    S O'Brien
    S Verstovsek
    T Kadia
    C Dinardo
    S Pierce
    X Huang
    N Pemmaraju
    M Diaz-Pines-Mateo
    J Cortes
    G Borthakur
    [J]. Leukemia, 2016, 30 : 268 - 273
  • [6] Treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) in the elderly with azacitidine and gemtuzumab ozogamicin (GO)
    Nand, S.
    Godwin, J.
    Smith, S.
    Barton, K.
    Germano, E.
    Stiff, P.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S8 - S8
  • [7] Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes
    Tsimberidou, A
    Estey, E
    Cortes, J
    Thomas, D
    Faderl, S
    Verstovsek, S
    Garcia-Manero, G
    Keating, M
    Albitar, M
    O'Brien, S
    Kantarjian, H
    Giles, F
    [J]. CANCER, 2003, 97 (06) : 1481 - 1487
  • [8] Predictors and Outcome of Acute Kidney Injury in Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome
    Lahoti, Amit
    Kantarjian, Hagop
    Salahudeen, Abdulla K.
    Ravandi, Farhad
    Cortes, Jorge E.
    Faderl, Stefan
    O'Brien, Susan
    Wierda, William
    Mattiuzzi, Gloria N.
    [J]. CANCER, 2010, 116 (17) : 4063 - 4068
  • [9] Lenalidomide in high-risk myelodysplastic syndrome and acute myelogenous leukemia associated with chromosome 5 abnormalities
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Faderl, Stefan
    Estrov, Zeev
    Verstovsek, Srdan
    Hood, Mary
    Kantarjian, Hagop
    [J]. BLOOD, 2007, 110 (11) : 437A - 437A
  • [10] Epigenetic therapy of high risk myelodysplastic syndrome and acute myelogenous leukemia
    Garcia-Manero, Guillermo
    [J]. CANCER INVESTIGATION, 2007, 25 : 37 - 37
12345